These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10389145)

  • 41. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.
    Culver KE; Szechtman H; Levant B
    Eur J Pharmacol; 2008 Sep; 592(1-3):67-72. PubMed ID: 18644362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validity of Quinpirole Sensitization Rat Model of OCD: Linking Evidence from Animal and Clinical Studies.
    Stuchlik A; Radostová D; Hatalova H; Vales K; Nekovarova T; Koprivova J; Svoboda J; Horacek J
    Front Behav Neurosci; 2016; 10():209. PubMed ID: 27833539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of quinpirole-induced compulsive-like behavior in rats by environmental changes: implications for OCD rituals and for exploration and navigation.
    Zadicario P; Ronen S; Eilam D
    BMC Neurosci; 2007 Mar; 8():23. PubMed ID: 17386094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats.
    Sullivan RM; Talangbayan H; Einat H; Szechtman H
    Neuroscience; 1998 Apr; 83(3):781-9. PubMed ID: 9483561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Memantine treatment does not affect compulsive behavior or frontostriatal connectivity in an adolescent rat model for quinpirole-induced compulsive checking behavior.
    Straathof M; Blezer ELA; Smeele CE; van Heijningen C; van der Toorn A; Buitelaar JK; Glennon JC; Otte WM; Dijkhuizen RM;
    Psychopharmacology (Berl); 2022 Aug; 239(8):2457-2470. PubMed ID: 35419637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
    De Carolis L; Schepisi C; Milella MS; Nencini P
    Psychopharmacology (Berl); 2011 Dec; 218(4):749-59. PubMed ID: 21660444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.
    Denys D; Zohar J; Westenberg HG
    J Clin Psychiatry; 2004; 65 Suppl 14():11-7. PubMed ID: 15554783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole.
    Einat H; Szechtman H
    Physiol Behav; 1995 Jan; 57(1):55-9. PubMed ID: 7878126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between compulsive behaviors and plastic changes in the dendritic spines of the prefrontal cortex and dorsolateral striatum of male rats.
    Hernández-González M; de la Torre-Vázquez J; Barrera-Cobos FJ; Flores-Soto M; Guevara MA; González-Burgos I
    Behav Brain Res; 2024 Oct; 475():115199. PubMed ID: 39182621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity modulation of the globus pallidus and the nucleus entopeduncularis affects compulsive checking in rats.
    Djodari-Irani A; Klein J; Banzhaf J; Joel D; Heinz A; Harnack D; Lagemann T; Juckel G; Kupsch A; Morgenstern R; Winter C
    Behav Brain Res; 2011 May; 219(1):149-58. PubMed ID: 21219934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
    Johnson EF; Szechtman H
    Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of curcumin on quinpirole induced compulsive checking: An approach to determine the predictive and construct validity of the model.
    Chimakurthy J; Murthy TE
    N Am J Med Sci; 2010 Feb; 2(2):81-6. PubMed ID: 22624119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nucleus accumbens core and pathogenesis of compulsive checking.
    Ballester González J; Dvorkin-Gheva A; Silva C; Foster JA; Szechtman H
    Behav Pharmacol; 2015 Feb; 26(1-2):200-16. PubMed ID: 25426580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density.
    Wolmarans de W; Brand L; Stein DJ; Harvey BH
    Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates.
    Albelda N; Joel D
    Neurosci Biobehav Rev; 2012 Jan; 36(1):47-63. PubMed ID: 21527287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High frequency stimulation and temporary inactivation of the subthalamic nucleus reduce quinpirole-induced compulsive checking behavior in rats.
    Winter C; Mundt A; Jalali R; Joel D; Harnack D; Morgenstern R; Juckel G; Kupsch A
    Exp Neurol; 2008 Mar; 210(1):217-28. PubMed ID: 18076877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multistrain probiotic rescinds quinpirole-induced obsessive-compulsive disorder phenotypes by reshaping of microbiota gut-brain axis in rats.
    Ghuge S; Rahman Z; Bhale NA; Dikundwar AG; Dandekar MP
    Pharmacol Biochem Behav; 2023 Nov; 232():173652. PubMed ID: 37804865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J
    Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.